Hiroshi Kawai, Ph.D.

Board Director CEO

Kyoto Univ., Ph.D.(Biochemistry),

Mitsubishi Tanabe, Mitsubishi Tanabe Holdings America

Led Business Development for 15 years

2019/10 Director of Socium.

2020/6 Board Director of Socium

Katsuhisa Horimoto, Ph.D.

Board Director CTO, Funder

Tokyo Univ. of Science, Ph.D.(Biophysics),The Univ. of Tokyo, AIST
>130 peer-reviewed papers on computational systems biology, 8 parents of algorithms
2017/9 CTO, Co-founder of Socium

2019/4 Invited Researcher of AIST, Visiting Professor of Saitama Medical Univ.

Junya Yamazaki, Ph.D.

Board Director

Kyoto Univ., Ph.D. (Molecular Biology)

Goldman Sachs, Jefferies, Takeda

Equity research, R&D finance, Portfolio management, BD support

2019/6 Principal of UTEC
2019/10 Board Director of Socium

Atsushi Shimada Patent atony, MBA

Vice President

Osaka Univ.,BS,

IE Business School., MBA,

Takeda, Bayer

2018/4 Venture Partner of UTEC,
2018/4 VP of Socium

Masashi Kitazawa, Ph.D.

Director R&D

Tohoku Univ.,Ph.D.(Pharmacy)

Astellas Pharma, AIST,

Led drug target discovery projects in academic and corporate research

2018/4 Manager of Socium.
2019/10 Director of Socium

Masaki Oka

Director Corporate Administration

Yokohama City Univ.,BA.(Accounting),KPMG AZSA LLC, SCS consulting HK.

Led Audit, financial advisory, listed in HK Main Board as IPO project manager
2019/6 Director of Socium